World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
21576
World Ranking
14775
National Ranking
7466

Overview

Kenneth A. Krohn is affiliated with Oregon Health & Science University in the United States. Their research spans multiple areas within medicine and biochemistry, genetics, and molecular biology, with a focus on molecular biology, radiology, nuclear medicine and imaging, pulmonary and respiratory medicine, cancer research, and oncology.

The scientist's recent publications include studies centered on medical imaging techniques and applications, histone deacetylase inhibitors research, advanced breast cancer therapies, protein degradation and inhibitors, radiomics and machine learning in medical imaging, cancer hypoxia, metabolism, and breast cancer treatment studies.

  • "18F-Fluoroestradiol PET Imaging in a Phase II Trial of Vorinostat to Restore Endocrine Sensitivity in ER+/HER2− Metastatic Breast Cancer" (2020), published in Journal of Nuclear Medicine
  • "Assessment of the Prognostic Value of Radiomic Features in 18F-FMISO PET Imaging of Hypoxia in Postsurgery Brain Cancer Patients: Secondary Analysis of Imaging Data from a Single-Center Study and the Multicenter ACRIN 6684 Trial" (2020), published in Tomography
  • "18F-fluorodeoxyglucose (FDG) PET or 18F-fluorothymidine (FLT) PET to assess early response to aromatase inhibitors (AI) in women with ER+ operable breast cancer in a window-of-opportunity study" (2021), published in Breast Cancer Research
  • "[18F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumab" (2022), published in Neuro-Oncology Practice
  • "Concepts for design and analysis of receptor radiopharmaceuticals: The Receptor-Binding Radiotracers series of meetings provided the foundation" (2020), published in Nuclear Medicine and Biology

Frequent coauthors who have collaborated with Kenneth A. Krohn include Jeanne Link, David A. Mankoff, Lanell M. Peterson, Brenda F. Kurland, and Jennifer M. Specht.

Publication venues where their work has appeared include:

  • Journal of Nuclear Medicine
  • Tomography
  • Breast Cancer Research
  • Neuro-Oncology Practice
  • Nuclear Medicine and Biology

The primary fields of study for the scientist are Medicine and Biochemistry, Genetics and Molecular Biology. Their research touches specific subfields such as Molecular Biology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Cancer Research, and Oncology.

Main topics of their work encompass:

  • Medical Imaging Techniques and Applications
  • Histone Deacetylase Inhibitors Research
  • Advanced Breast Cancer Therapies
  • Protein Degradation and Inhibitors
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer, Hypoxia, and Metabolism
  • Breast Cancer Treatment Studies

Best Publications

  • Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: A pretherapy study of 37 patients

    Janet S. Rasey;Wui Jin Koh;Margaret L. Evans;Lanell M. Peterson

  • Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy

    Jeffrey M. Arbeit;J. Martin Brown;K. S.Clifford Chao;J. Donald Chapman

  • Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole.

    Wui Jin Koh;Janet S. Rasey;Margaret L. Evans;John R. Grierson

  • Molecular imaging of hypoxia.

    Kenneth A. Krohn;Jeanne M. Link;Ralph P. Mason

  • Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer

    Hannah M. Linden;Svetlana A. Stekhova;Jeanne M. Link;Julie R. Gralow

  • Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging.

    Joseph G. Rajendran;David A. Mankoff;Finbarr O'Sullivan;Lanell M. Peterson

  • Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer

    Joseph G. Rajendran;David L. Schwartz;David L. Schwartz;Janet O'Sullivan;Lanell M. Peterson

  • Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography

    Wui Jin Koh;Kenneth S. Bergman;Janet S. Rasey;Lanell M. Peterson

  • Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.

    O W Press;J F Eary;C C Badger;P J Martin

  • Imaging oxygenation of human tumours

    Anwar R Padhani;Kenneth A. Krohn;Jason S Lewis;Markus L Alber

  • Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.

    S M Larson;J A Carrasquillo;K A Krohn;J P Brown

  • Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.

    Alexander M. Spence;Mark Muzi;Kristin R. Swanson;Finbarr O'Sullivan

  • [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression.

    J. G. Rajendran;D. C. Wilson;E. U. Conrad;L. M. Peterson

  • Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol

    Lanell M. Peterson;David A. Mankoff;Thomas Lawton;Kevin Yagle

  • FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma.

    David L. Schwartz;Eric Ford;Joseph Rajendran;Bevan Yueh

  • Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia

    Janet S. Rasey;Wui Jin Koh;John R. Grierson;Zdenka Grunbaum

  • The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development

    Gary J. Kelloff;Kenneth A. Krohn;Steven M. Larson;Ralph Weissleder

  • FDG-PET prediction of head and neck squamous cell cancer outcomes

    David L. Schwartz;David L. Schwartz;Joseph Rajendran;Bevan Yueh;Marc D. Coltrera

  • Characterization of radiolabeled fluoromisonidazole as a probe for hypoxic cells

    Janet S. Rasey;Zdenka Grunbaum;Sara Magee;Norma J. Nelson

  • Molecular Imaging of Hypoxia

    Satish K. Chitneni;Gregory M. Palmer;Michael R. Zalutsky;Mark W. Dewhirst

Frequent Co-Authors

David A. Mankoff
David A. Mankoff University of Pennsylvania
Paul E. Kinahan
Paul E. Kinahan University of Washington
Oliver W. Press
Oliver W. Press University of Washington
Todd L. Richards
Todd L. Richards University of Washington
Irwin D. Bernstein
Irwin D. Bernstein Fred Hutchinson Cancer Research Center
Karl Erik Hellström
Karl Erik Hellström University of Washington
Ingegerd Hellström
Ingegerd Hellström University of Washington
Steven M. Larson
Steven M. Larson Memorial Sloan Kettering Cancer Center
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Michael J. Welch
Michael J. Welch Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative and related online degrees can open up various career pathways in healthcare. For those who are already registered nurses, pursuing a BSN is more affordable than ever, thanks to cheap rn to bsn programs offered by many universities. These flexible options make it easier to advance your qualifications while balancing work and personal commitments.

If you don’t have a nursing background but want to enter the field quickly, direct entry msn programs for non-nurses online offer a fast-track route to becoming a qualified nurse. These accelerated programs are designed to get you into the workforce sooner.

Prospective students interested in nursing but concerned about competitiveness may benefit from learning whats the easiest nursing program to get into? to maximize their chances of acceptance.

For those seeking non-clinical careers in healthcare, medical billing and coding is a popular choice. Many top schools offer online programs with financial assistance. Check out these medical billing and coding financial aid opportunities to start your journey.

Best Scientists Citing Kenneth A. Krohn

Trending Scientists

Recently Published Articles